公开(公告)号：EP1572868A2

公开(公告)日：2005-09-14

申请号：EP02728746.5

申请日：2002-04-12

申请人： Wyeth Holdings Corporation

发明人： ZAGURSKY, Robert, John ,  MASI, Amy, Wadhams ,  GREEN, Bruce, Arthur ,  CHAKRAVARTI, Deb, Narayan ,  RUSSELL, David, Parrish ,  WOOTERS, Joseph, Lawrence

IPC分类号： C12N1/00

CPC分类号： C12N9/88 ,  A61K38/00 ,  A61K39/00 ,  A61K2039/53 ,  C07K14/3156 ,  C07K2319/00 ,  C12Q1/689 ,  C12Y305/01011

摘要： The present invention relates to newly identified open reading frames comprised within the genomic nucleotide sequence of Streptococcus pneumoniae, wherein the open reading frames encode polypeptides that are surface localized on Streptococcus pneumoniae. Thus, the invention relates to Streptococcus pneumoniae open reading frames that encode polypeptide antigens, polypeptides, preferably antigenic polypeptides, encoded by the Streptococcus pneumoniae open reading frames, vectors comprising open reading frame sequences and cells or animals transformed with these vectors. The invention relates also to methods of detecting these nucleic acids or polypeptides and kits for diagnosing Streptococcus pneumoniae infection. The invention finally relates to pharmaceutical compositions, in particular immunogenic compositions, for the prevention and/or treatment of bacterial infection, in particular infections with Streptococcus pneumoniae. In particular embodiments, the immunogenic compositions are used for the treatment or prevention of systemic diseases which are induced or exacerbated by Streptococcus pneumoniae. In other embodiments, the immunogenic compositions are used for the treatment or prevention of non-systemic diseases, particularly of the otitis media, which are induced or exacerbated by Streptococcus pneumoniae.